register

ESG

Sanofi staff roll up sleeves, joining Australia’s $566 billion ‘do-good’ economy

Health Industry Hub | November 7, 2025 |

Nearly two-thirds of Australians aged 15 and over, around 14.1 million people, volunteer in some form. The contribution is not only social and cultural; it is also economically significant. For every $1 invested in volunteering, there is an estimated $5 return in community value.

Of this group, 32% volunteer in formal settings with organisations such as not-for-profits, government agencies and private organisations. In these structured environments, volunteers contribute an average of 16.7 hours per month.

This context underpins Sanofi Australia’s recently completed annual We Volunteer initiative. Across the month of October, employees from the company dedicated hundreds of volunteer hours to five community and environmental organisations: Foodbank, FareShare, OzHarvest, Clean Up Australia and Vinnies.

Activities ranged from sorting and distributing food and preparing meals for communities facing food insecurity, to supporting Vinnies’ end-of-year outreach program and cleaning along the Parramatta River. The initiative was coordinated to ensure support reached areas of need, from local environmental preservation to food relief.

Luke Cornish, Head of Corporate Affairs, Sanofi Australia & New Zealand, said “As a healthcare company we know our responsibility extends beyond delivering innovative medicines, to being an active corporate citizen in the communities we serve. Our team’s action and over 400 hours of volunteering achieved during October demonstrates their belief in that responsibility.

“I’m proud of Team Sanofi for prioritising these special volunteering opportunities while maintaining their unwavering commitment to ensuring Australians can access our medicines and vaccines. We’re improving people’s lives every day.”

Evidence continues to show that the benefits of volunteering extend to workplaces. Among volunteers, 57.1% believe volunteering makes them more productive at work, compared with 34% of non-volunteers. This suggests a meaningful correlation between volunteering and improved professional performance. The estimated productivity uplift linked to volunteering is valued at $92.7 billion.

Overall, the combined social and economic value of formal and informal volunteering – the largest labour force in the country – is estimated at more than $566 billion, highlighting volunteering as a critical contributor to national wellbeing, organisational health, and community resilience.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.